| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.291 | 27.751 | 28.731 | 29.773 | 35.551 | 57.428 | 44.451 | 43.596 | 47.797 | 34.614 |
| Total Income - EUR | 27.291 | 27.751 | 28.731 | 29.773 | 37.621 | 63.007 | 88.925 | 88.237 | 102.285 | 83.183 |
| Total Expenses - EUR | 24.924 | 26.032 | 27.779 | 29.434 | 37.095 | 44.422 | 64.757 | 72.161 | 72.596 | 69.576 |
| Gross Profit/Loss - EUR | 2.366 | 1.719 | 952 | 339 | 526 | 18.585 | 24.167 | 16.076 | 29.689 | 13.607 |
| Net Profit/Loss - EUR | 1.547 | 1.442 | 664 | 41 | 149 | 18.010 | 23.340 | 15.326 | 28.718 | 12.174 |
| Employees | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 |
Check the financial reports for the company - Provetmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.402 | 5.257 | 5.089 | 5.154 | 8.711 | 10.891 | 16.997 | 12.188 | 4.881 | 4.624 |
| Current Assets | 8.574 | 10.440 | 11.043 | 13.337 | 10.087 | 37.180 | 39.528 | 41.336 | 52.182 | 53.937 |
| Inventories | 3.481 | 2.394 | 1.284 | 1.434 | 2.411 | 11.642 | 11.933 | 20.898 | 24.967 | 26.071 |
| Receivables | 1.212 | 1.606 | 2.647 | 3.683 | 2.675 | 7.836 | 12.153 | 8.470 | 19.463 | 23.682 |
| Cash | 3.881 | 6.440 | 7.112 | 8.220 | 5.001 | 17.703 | 15.443 | 11.968 | 7.752 | 4.184 |
| Shareholders Funds | 7.555 | 8.920 | 9.433 | 9.301 | 9.270 | 27.105 | 32.257 | 33.915 | 46.049 | 47.935 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.420 | 6.776 | 6.699 | 9.189 | 9.528 | 20.966 | 24.269 | 19.608 | 11.014 | 10.625 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Provetmed S.r.l.